Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation

Experimental Hematology

Volumn 37, Issue 10, 2009, Pages

  Mazharian, Alexandra ^a   Watson, Steve P ^a   Séverin, Sonia ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GLYCOPROTEIN IB; GLYCOPROTEIN IIB; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMUR; FETUS LIVER; LIVER CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MOUSE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; STROMA CELL; THROMBOCYTE; TIBIA;

MURINAE; MUS;

EID: 70249121773     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.07.006     Document Type: Article

References (47)

1. Deutsch V.R., and Tomer A. Megakaryocyte development and platelet production. Br J Haematol 134 (2006) 453-466
2. Schulze H., and Shivdasani R.A. Mechanisms of thrombopoiesis. J Thromb Haemost 3 (2005) 1717-1724
3. Zimmet J., and Ravid K. Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Exp Hematol 28 (2000) 3-16
4. de Sauvage F.J., Hass P.E., Spencer S.D., et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369 6481 (1994) 533-538
5. Kaushansky K., Broudy V.C., Lin N., et al. Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A 92 (1995) 3234-3238
6. Lok S., Kaushanksy K., Holly R.D., et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369 6481 (1994) 565-568
7. Sheridan W.P., Choi E., Toombs C.F., Nichol J., Fanucchi M., and Basser R.I. Biology of thrombopoiesis and the role of Mpl ligand in the production and function of platelets. Platelets 8 (1997) 319-332
8. Wendling F., and Vainchenker W. Thrombopoietin and its receptor. Eur Cytokine Netw 9 (1998) 221-231
9. Drachman J.G., Griffin J.D., and Kaushansky K. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl. J Biol Chem 270 (1995) 4979-4982
10. Yamada M., Komatsu N., Okada K., Kato T., Miyazaki H., and Miura Y. Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line. Biochem Biophys Res Commun 217 (1995) 230-237
11. Olthof S.G., Fatrai S., Drayer A.L., Tyl M.R., Vellenga E., and Schuringa J.J. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis. Stem Cells 26 (2008) 1732-1742
12. Shide K., Shimoda H.K., Kumano T., et al. Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F. Leukemia 22 (2008) 87-95
13. Wickrema A., and Crispino J.D. Erythroid and megakaryocytic transformation. Oncogene 26 (2007) 6803-6815
14. Raman M., Chen W., and Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 26 (2007) 3100-3112
15. Rouyez M.C., Boucheron C., Gisselbrecht S., Disanter-Fourt I., and Porteu F. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol Cell Biol 17 (1997) 4991-5000
16. Herrera R., Hubbell S., Decker S., and Petruzzelli L. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Exp Cell Res 238 (1998) 407-414
17. Racke F.K., Lewandowska K., Goueli S., and Goldfarb A.N. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J Biol Chem 272 (1997) 23366-23370
18. Whalen A.M., Galasinksi S.C., Shapiro P.S., Nahreini T.S., and Ahn N.G. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol Cell Biol 17 (1997) 1947-1958
19. Melemed A.S., Ryder J.W., and Vik T.A. Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells. Blood 90 (1997) 3462-3470
20. Fichelson S., Freyssinier J.M., Picard F., et al. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Blood 94 (1999) 1601-1613
21. Guerriero R., Mattia G., Testa U., Chelucci C., et al. Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood 97 (2001) 2587-2595
22. Guerriero R., Parolini I., Testa U., et al. Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes. J Cell Sci 119 (2006) 744-752
23. Miyazaki R., Ogata H., and Kobayashi Y. Requirement of thrombopoietin-induced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation. Ann Hematol 80 (2001) 284-291
24. Rojnuckarin P., Drachman J.G., and Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood 94 (1999) 1273-1282
25. Minamiguchi H., Kimura T., Urata Y., et al. Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways. Br J Haematol 115 (2001) 175-185
26. Jiang F., Jia Y., and Cohen I. Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation. Blood 99 (2002) 3579-3584
27. Rojnuckarin P., and Kaushansky K. Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase calpha. Blood 97 (2001) 154-161
28. Eriksson M., Arminen L., Karjalainen-Lindsberg M.L., and Leppä S. AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells. Exp Cell Res 304 (2005) 175-186
29. Jacquel A., Herrant M., Defamie V., et al. A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene 25 (2006) 781-794
30. Dumon S., Heath V.L., Tomlinson M.G., Göttgens B., and Frampton J. Differentiation of murine committed megakaryocytic progenitors isolated by a novel strategy reveals the complexity of GATA and Ets factor involvement in megakaryocytopoiesis and an unexpected potential role for GATA-6. Exp Hematol 34 (2006) 654-663
31. Lecine P., Blank V., and Shivdasani R. Characterization of the hematopoietic transcription factor NF-E2 in primary murine megakaryocytes. J Biol Chem 273 (1998) 7572-7578
32. Dhanjal T.S., Pendaries C., Ross E.A., et al. A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice. Blood 109 (2007) 4237-4244
33. Larson M.K., and Watson S.P. Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3. Blood 108 (2006) 1509-1514
34. Smith J.A., Maloney D.J., Hecht S.M., and Lannigan D.A. Structural basis for the activity of the RSK-specific inhibitor, SL0101. Bioorg Med Chem 15 (2007) 5018-5034
35. Borsch-Haubold A.G., Pasquet S., and Watson S.P. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J Biol Chem 273 (1998) 28766-28772
36. Hattori K., Heissig B., and Rafii S. The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1. Leuk Lymphoma 44 (2003) 575-582
37. Nilsson S.K., Debatis M.F., Dooner M.S., Madri J.A., Quesenberry P.J., and Becker P.S. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ. J Histochem Cytochem 46 (1998) 371-377
38. Cheresh D.A., Leng J., and Klemke R.L. Regulation of cell contraction and membrane ruffling by distinct signals in migratory cells. J Cell Biol 146 (1999) 1107-1116
39. Glading A., Bodnar R.J., Reynolds I.J., et al. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol 24 (2004) 2499-2512
40. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., and Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137 (1997) 481-492
41. Webb D.J., Donais K., Whitmore L.A., et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6 (2004) 154-161
42. Italiano Jr. J.E., Lecine P., Shivdasan R.A., and Hartwig J.H. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 147 (1999) 1299-1312
43. Patel S.R., Richardson J.L., Schulze H., et al. Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. Blood 106 (2005) 4076-4085
44. Tablin F., Castro M., and Leven R.M. Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation. J Cell Sci 97 (1990) 59-70
45. Ray L.B., and Sturgill T.W. Insulin-stimulated microtubule associated protein kinase is detectable by analytical gel chromatography as a 35-kDa protein in myocytes, adipocytes, and hepatocytes. Arch Biochem Biophys 262 (1988) 307-313
46. Sturgill T.W., Ray L.B., Erikson E., and Maller J.L. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334 6184 (1988) 715-718
47. Amos L.A., and Schlieper D. Microtubules and maps. Adv Protein Chem 71 (2005) 257-798